Skip to main content
. 2018 Jun 25;18:285. doi: 10.1186/s12879-018-3198-2

Fig. 4.

Fig. 4

Temporal trends of CD4/CD8 ratio and platelet/lymphocyte ratio (PLR) before and after switch in the TDF-reducing therapy group